|
Tufts CSDD to Offer 4–Day Training Course in Drug Development, Feb. 18–21
December 18, 2002
Ten Percent of New Prescription Drugs Generate Half of the Industry's Net Returns
December 13, 2002
Tufts Center for the Study of Drug Development to Host Forum on Drug R&D Nov. 7 in Philadelphia
October 8, 2002
Tufts Center for the Study of Drug Development Quantifies Savings from Boosting New Drug R&D Efficiency
September 9, 2002
FDA Review and Approval Times for New Drugs Have Shortened
July 29, 2002
Tufts Center for the Study of Drug Development to Host Course on Leading Pharmaceutical Teams
July 18, 2002
Biotechnology Has Become Vital to Orphan Drug R&D
May 22, 2002
Tufts Center for the Study of Drug Development Launches Institute for Professional Development
April 16, 2002
Disease Managers Say Increased Spending on Prescription Drugs Cuts Hospital Inpatient Costs
March 12, 2002
Use of Disease Management Programs Will Grow in 2002
January 24, 2002
Biotech Firms Focus R&D Agenda on Products of High Therapeutic Importance, Including Vaccines to Fight Bioterrorism
January 22, 2002
New Demands on FDA Will Slow the Approval of New Drugs
January 17, 2002
Drug Companies Must Improve R&D Efficiency to Remain Competitive
January 14, 2002
Return to Top
|